The Lupus Research Institute (LRI) and the Alliance for Lupus Research (ALR) applaud the members of the U.S. House of Representatives for passing the 21st Century Cures Act today with a vote of 344 to 77 – an overwhelming vote of support!
Its passage in the House represents a major step towards legislation that can significantly improve research for lupus and other diseases. Learn more from LRI staffer, lupus advocate and patient Amy Caron on what 21st Century Cures could mean for people with lupus.
We particularly appreciate that the #Cures2015 bill addresses requests LRI and ALR advocates voiced that:
- Strengthen National Institutes of Health (NIH) biomedical research
- Increase the numbers of clinical trials and streamline how they’re conducted
- Increase patient participation in the research and drug approval processes
- Provide incentives to foster more clinical research, networks and clinical trials without compromising drug safety
We thank the champions and authors of this bill for their vision and determination: Fred Upton (R-MI), Diana DeGette (D-CO), Frank Pallone, Jr. (D-NJ), Joe Pitts (R-PA) and Gene Green (D-TX).
As these representatives commented in a press release from the House Committee on Energy and Commerce, “The 344 votes today should be a springboard for action. On to the Senate.”
The LRI and ALR will continue to do our part to push for parallel legislation in development by the U.S. Senate. Our particular goal – to involve lupus patients in research that accelerates the discovery, development, and delivery of better, safer treatments and a cure.